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Morphological analysis of a conditional yeast mutant in acetyl-
CoA carboxylase acc1ts/mtr7, the rate-limiting enzyme of fatty
acid synthesis, suggested that the synthesis of C26 VLCFAs (very-
long-chain fatty acids) is important for maintaining the structure
and function of the nuclear membrane. To characterize this
C26-dependent pathway in more detail, we have now examined
cells that are blocked in pathways that require C26. In yeast, cer-
amide synthesis and remodelling of GPI (glycosylphosphatidyl-
inositol)-anchors are two pathways that incorporate C26 into lipids.
Conditional mutants blocked in either ceramide synthesis or the
synthesis of GPI anchors do not display the characteristic alter-
ations of the nuclear envelope observed in acc1ts, indicating that
the synthesis of another C26-containing lipid may be affected
in acc1ts mutant cells. Lipid analysis of isolated nuclear mem-
branes revealed the presence of a novel C26-substituted PI (phos-
phatidylinositol). This C26-PI accounts for approx. 1% of all the
PI species, and is present in both the nuclear and the plasma
membrane. Remarkably, this C26-PI is the only C26-containing
glycerophospholipid that is detectable in wild-type yeast, and
the C26-substitution is highly specific for the sn − 1 position
of the glycerol backbone. To characterize the biophysical pro-
perties of this lipid, it was chemically synthesized. In contrast to
PIs with normal long-chain fatty acids (C16 or C18), the C26-PI
greatly reduced the bilayer to hexagonal phase transition of lipo-
somes composed of 1,2-dielaidoyl-sn-glycero-3-phosphoethanol-
amine (DEPE). The biophysical properties of this lipid are thus
consistent with a possible role in stabilizing highly curved mem-
brane domains.
Key words: 1,2-dielaidoyl-sn-glycero-3-phosphoethanolamine,
fatty acid, membrane curvature, nuclear pore complex, subcellular
membrane, yeast.
INTRODUCTION
Cell membranes are complex macromolecular assemblies of lipids
and proteins. Although the various possible functions of lipids in
this assembly are yet to be completely understood, work from the
last decade indicates that lipids serve a more organizing function
than had initially been supposed [1]. For example, different
subcellular membranes have different lipid compositions and
even within the same membrane, different types of lipids may
be asymmetrically distributed between the two halves of the lipid
bilayer [2]. Moreover, within the plane of the membrane different
lipids can display a surprising degree of lateral organization
[3]. These domain-forming properties of different types of lipids
appear to be functionally important, as indicated, for example, by
the observation that microdomains formed by the association of
sphingolipids and cholesterol can serve to concentrate interacting
proteins and thereby might assist in the sorting of membrane-
anchored proteins along their trafficking pathways [4].
The physicochemical membrane parameters more generally
affect the function of integral membrane proteins. For example,
protein transmembrane domains are thought to interact preferen-
tially with lipids of matching acyl chain length [5]. Such protein–
membrane interactions are thus sensitive to subtle changes in the
lipid composition of the membrane. Thus, in vivo, the fatty acid
acyl chain length, degree of unsaturation and the nature of the lipid
Abbreviations used: DCC, dicyclohexylcarbodi-imide; DEPE, 1,2-dielaidoyl-sn-glycero-3-phosphoethanolamine; ER, endoplasmic reticulum; ESI,
electrospray ionization; GPI, glycosylphosphatidylinositol; LCFA, long-chain fatty acid; nano-ESI-MS/MS, nano-electrospray ionization tandem mass spec-
trometry; NPC, nuclear pore complex; PI, phosphatidylinositol; C26-PI, sn-1-O-hexacosanoyl-sn-2-O-palmitoyl-PI; PMB, 3-p-methoxybenzyl; PS, phospha-
tidylserine; TH, bilayer to hexagonal phase transition temperature; TM, Lβ to Lα phase transition temperature; (V)LCFA, (very-)long-chain fatty acid.
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head group are important parameters that can modify the stru-
cture and function of integral membrane proteins [6].
The NPC (nuclear pore complex) is a giant protein-aqueous
channel that spans the outer and inner nuclear membranes of euka-
ryotic cells [7]. The NPC itself is anchored to the nuclear envelope
by integral membrane proteins that define the ‘pore membrane’
domain of the NPC [8]. Even though the precise organization
of the membrane around the NPC is not known, it is generally
assumed that inner and outer nuclear membranes are continuous
with each other and that they form a 180◦ turn at the NPC [9].
A connection between fatty acid synthesis and the structure of
the nuclear envelope in yeast is suggested by the observation that
a conditional yeast acetyl-CoA carboxylase mutant, acc1ts/mtr7,
affects the structure and function of the nuclear envelope/NPC
[10–12]. acc1ts/mtr7 mutant cells are defective in nuclear mRNA
transport and display a severe perturbation of the nuclear envelope,
characterized by the separation of the inner and outer nuclear
membranes and the formation of vesicles within the inter-
membrane space. Similar structural defects were observed in
mutants in NPC protein (nucleoporins), such as members of the
Nup84 complex [13–15].
Acetyl-CoA carboxylase, Acc1p, is the rate-limiting enzyme of
fatty acid synthesis. It catalyses the ATP-dependent carboxylation
of acetyl-CoA to malonyl-CoA, which then serves as the two-
carbon-unit donor for the synthesis of LCFAs (long-chain fatty
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Scheme 1 C26-dependent pathways in yeast
Schematic overview of pathways that require LCFAs and VLCFAs, and are thus dependent on
the function of Acc1p. See the Introduction for more details.
acids). The fact that the temperature-sensitive growth phenotype
of acc1ts and the lethality of an acc1∆ null allele are not rescued
by LCFA supplementation indicated that malonyl-CoA is required
for a second essential function that is independent of the synthesis
of LCFAs [10–12,16]. This second function of Acc1 is to provide
malonyl-CoA for the elongation of LCFAs to VLCFAs (very-
LCFAs) by an ER (endoplasmic reticulum)-bound elongation
complex [17]. Since neither fatty acid auxotrophic acc1 mutant
cells nor wild-type cells treated with cerulenin, an inhibitor of
the fatty acid synthetase, display the nuclear envelope alteration
characteristic of acc1ts, we proposed that VLCFA synthesis is
required for a functional nuclear envelope [10–12,16]. This pro-
position is supported by the observation that supplementation of
acc1ts mutant cells with C16 and/or C18 LCFAs does not rescue
the defect in mRNA transport. Taken together, these observations
indicate that an as-yet-uncharacterized VLCFA-dependent pro-
cess might be important to maintain the structure and function
of the yeast nuclear membrane, and that a block in this process,
as caused by acc1ts, results in the phenotypic alterations of the
nuclear membrane [10,11].
C26 is the major VLCFA in yeast. It comprises 1–2% of the
total fatty acid composition. The C26 acyl chain is an important
structural component of the ceramide moiety of sphingolipids and
GPI (glycosylphosphatidylinositol)-anchored proteins, of which
the synthesis of both is essential in yeast. The significance of the
very long acyl chain of ceramide is underlined by the observation
that strains with a dominant allele in an acyl transferase (SLC1-1;
sphingolipid compensation) bypass the essential requirement for
ceramide by synthesizing novel inositol glycerophospholipids
substituted with a C26 fatty acid in the sn − 2 position of the
glycerol. In addition, this PI (phosphatidylinositol) acquires head
group modifications typically found only on sphingolipids, and
thus structurally and functionally mimics sphingolipids [18,19].
Apart from ceramide, the C26 VLCFA is also present in the lipid
moiety of GPI-anchored proteins [20] and the two storage lipids,
steryl esters and triacylglycerol [21]. In contrast with GPI anchors
[22], neutral lipids are not essential in yeast [23]. An overview
of these possible C26-dependent processes is shown in Scheme 1.
The aim of the present study was to identify and characterize the
C26-dependent processes that may account for the phenotypic
alteration of the nuclear envelope in acc1ts mutant cells.
EXPERIMENTAL
Isolation of yeast subcellular membranes
The wild-type Saccharomyces cerevisiae strain used for these ex-
periments was YPH259 (MATα ade2-101 ura3-52 his3-200
leu2-1 lys2-801 trp1-63). The lcb1-100 conditional mutant
was RH2607, MATa end8-1 leu2 ura3 his4 bar1 [24]. gpi2-
5A (his4 ura3) was kindly given by Dr P. Orlean (Department
of Microbiology, University of Illinois at Urbana-Champaign,
Urbana, IL, U.S.A.) [25]. Fermenter cultures (10 litre flasks) of
YPH259 were grown in YPD (1% yeast extract/2% bactopep-
tone/2% glucose) at 30 ◦C to early-exponential phase. Cells
were harvested by centrifugation and were converted into sphero-
plasts. Nuclei were then enriched by sucrose density-gradient
centrifugation as described previously [26]. Plasma membranes
were isolated following a procedure described previously [27].
Protein analysis
Before quantification, proteins were precipitated with 10% tri-
chloroacetic acid and solubilized in 0.1% (w/v) SDS/0.1 M
NaOH. Quantification was performed using the Folin phenol
reagent and BSA as the standard. Proteins were separated by
SDS/PAGE and transferred to nitrocellulose filters (Hybond-C;
Amersham Biosciences, Little Chalfont, Bucks., U.K.). Relative
enrichment and degree of contamination of subcellular fractions
was determined by Western blot analysis using the antibodies
against the marker proteins (shown in Table 2). Antisera against
yeast plasma-membrane ATPase, carboxypeptidase Y and Kar2p
were kindly given by: Dr R. Serrano (Institute of Molecular
and Cellular Biology of Plants, Polytechnic University of
Valencia, Valencia, Spain); Dr D. Wolf (Institute of Biochemistry,
Stuttgart University, Germany); Dr R. Fuller (Department of
Biochemistry, Stanford University School of Medicine, Stanford,
CA, U.S.A.); and Dr R. Schekman (Department of Mole-
cular and Cell Biology, University of California, Berkeley, CA,
U.S.A.). The antibody against the nucleolar protein Nop1p was
obtained from Dr J. Aris (Department of Anatomy and Cell
Biology, University of Florida, Gainesville, FL, U.S.A.), and the
antibody against porin was obtained from Dr G. Daum (Institute
of Biochemistry, Technical University of Graz, Graz, Austria).
Lipid and fatty acid analyses
Lipids were extracted and individual phospholipids were sep-
arated by two-dimensional TLC using chloroform/methanol/25%
ammonia (65:35:5, v/v) for the first and chloroform/acetone/
methanol/acetic acid/water (50:20:10:10:5, v/v) for the second
direction. Spots detected after exposure to iodine vapour were
scraped off and lipids were extracted with chloroform/methanol
(1:4). Total and individual phospholipids were quantified as des-
cribed previously [28].
The positional distribution of fatty acids was determined by
phospholipase A2 cleavage of individual phospholipids. The lipid
was resuspended in a solution containing 100 mM Tris/HCl,
pH 8.0, 10 mM CaCl2, 0.05% Triton X-100 and 15 units of
phospholipase A2 [from the spectacled cobra (Naja naja); Sigma
Chemical Co., St Louis, MO, U.S.A.] and incubated at 37 ◦C for
4 h. Lysophospholipids were then separated from free fatty acids
by TLC with chloroform/methanol/water (65:25:4, v/v).
After mild (0.1 M NaOH for 1 h at 30 ◦C) or strong [2 M KOH
in methanol/water (2:1, v/v) for 18 h at 80 ◦C] alkaline hydrolysis
of lipids, fatty acids were converted into methyl esters by BF3-
catalysed methanolysis, and separated by GLC on a Hewlett–
Packard 5890 equipped with an ultra 2 capillary column (5%
diphenyl/95% dimethylpolysiloxane) and FID (flame ionization
detector), as described previously [10]. C13 and C23 fatty acids
added to each sample before alkaline hydrolysis served as an
internal standard. In every experiment, blank samples containing
no lipids were processed through all steps of manipulation. Fatty
acids were identified using commercial methyl ester standards
(NuCheck Inc., Elysian, MN, U.S.A.) and, in selected cases, by
c© 2004 Biochemical Society
C26-substituted phosphatidylinositol in yeast 943
GLC–MS analysis using a Hewlett–Packard 8590 II Plus GLC
coupled with a Hewlett–Packard 5972 mass selective detector.
Samples (1 µl) were injected in the splitless mode; the injector
temperature was set to 230 ◦C, and the detector temperature to
280 ◦C. Other details were as follows: ionization, 70 eV; scan
mode, 35–400 amu; oven temperature was 150 ◦C for 1 min, fol-
lowed by a temperature ramp of 10 ◦C/min to 290 ◦C for 10 min;
helium 5.0 was used as the carrier gas [0.81 bar (1 bar ≡ 105 Pa)
at 150 ◦C, constant flow]; the column was an HP-5MS.
Mass spectrometry
After solvent evaporation, samples were resuspended in methanol
and processed further for MS, as described previously [28]. Nano-
ESI-MS/MS (nano-electrospray ionization tandem mass spectro-
metry) analysis performed on a Micromass QII triple-stage
quadrupole tandem mass spectrometer (Waters, Milford, MA,
U.S.A.) was operated equipped with a nano-ESI source (Z spray)
from Micromass. Argon was used as the collision gas at a nomi-
nal pressure of 2.5 × 10−3 mbar. The cone voltage was set to
30 V. Resolution of Q1 and Q3 was set to achieve isotope re-
solution. Detection of PI was performed by parent ion scan-
ning for fragment ion m/z 241 at collision energy 50 eV; scanning
for hexacosanoic acid-containing lipid species was performed by
parent ion scanning for fragment ion 395 at a collision energy
of 50 eV. Product ion scanning of synthetic PI (26:0/C16:0) was
performed by applying a collision energy of 50 eV.
Electron microscopy
For ultrastructural examination, cells were fixed in 4% (w/v)
paraformaldehyde/5% (v/v) glutaraldehyde in 0.1 M cacodylate
buffer, pH 7.0, and 1 mM CaCl2 for 90 min at room temperature.
Then, cells were washed in buffer with 1 mM CaCl2 for 1 h and
incubated for 1 h with a 2% aqueous solution of KMnO4. Fixed
cells were washed in distilled water for 30 min and incubated
in 1% sodium metaperjodate for 20 min. Samples were rinsed in
distilled water for 15 min and post-fixed for 2 h in 2% OsO4
buffered with 0.1 M cacodylate at pH 7.0. After another wash
with buffer for 30 min, the samples were dehydrated in a graded
series of ethanol (50–100%, with en bloc staining in 2% uranyl
acetate in 70% ethanol overnight) and embedded in Spurr resin.
Ultrathin sections were stained with lead citrate and viewed with
a Philips CM 10 electron microscope.
Synthesis of C26-PI (sn-1-O-hexacosanoyl-sn-2-O-palmitoyl-PI)
Selective acylation and phosphoramidite synthesis was performed
as described previously [29]. A mixture of PMB (3-p-methoxy-
benzyl) glycerol (21 mg, 0.10 mmol), hexacosanoic acid (47 mg,
0.12 mmol) and 4,4-dimethylaminopyridine (1 mg, catalytic
amount) were suspended in CH2Cl2 (1.0 ml) and cooled to 0 ◦C. A
solution of DCC (dicyclohexylcarbodi-imide; 27 mg, 0.13 mmol)
in CH2Cl2 (1.0 ml) was added dropwise, and the mixture was
stirred overnight slowly, warming to room temperature. The mix-
ture was filtered through a pad of Celite, concentrated, and the
1-acylglyceryl ether was purified by column chromatography
(silica gel, 25% ethyl acetate/hexane) to obtain a white solid
(26 mg, 45%). Next, 16 mg (0.027 mmol) palmitic acid (13 mg,
0.051 mmol) and 4,4-dimethylaminopyridine were dissolved in
CH2Cl2 (1.0 ml). DCC (9.0 mg, 0.044 mmol) was added, and the
mixture was stirred overnight at room temperature. The mixture
was concentrated in vacuo and purified by column chromato-
graphy (silica gel, 15% ethyl acetate/hexane) to give 21 mg
(95%) of the PMB-protected diacylglycerol. Then, oxidative re-
moval of the PMB ether was achieved by dissolving the ether
in wet CH2Cl2 (1.0 ml), adding dichlorodicyanoquinone (16 mg,
0.07 mmol) and stirring the mixture overnight at room tem-
perature. The solution was washed with 10%NaHCO3, dried over
MgSO4, and concentrated to give the diacylglycerol as a crude
white solid (44 mg) in quantitative yield.
Finally, the phosphoramidite was prepared according to liter-
ature protocols described previously [29]. Thus sn-1-O-hexa-
cosanoyl-sn-2-O-palmitoylglycerol (25 mg, 0.035 mmol) was
dissolved in CH2Cl2 (1.25 ml) and cooled to 0 ◦C. Di-isopropyl-
ethylamine (10 µl, 0.056 mmol) was added, followed by a solu-
tion of benzyloxychlorodi-isopropylamine phosphine (26 mg,
0.095 mmol) in CH2Cl2 (1.0 ml). The mixture was stirred for 3 h,
while slowly warming to room temperature. It was then diluted
with CH2Cl2, extracted with 10% NaHCO3 and then dried over
MgSO4. The solution was concentrated to leave an orange oil that
was purified by column chromatography [silica gel, hexanes/ethyl
acetate/triethylamine (60:10:1)] to leave a white solid (22.5 mg,
68%), which was used within 1 week.
For synthesis of C26-PI, coupling was performed following
known protocols [29–31]. Thus 2,3,4,5,6-pentakisbenzyl-1-D-
myo-inositol (9.4 mg, 0.015 mmol), which had been resolved as
the camphanate ester [32], was dissolved in CH2Cl2 (0.5 ml),
tetrazole (5.6 mg, 0.08 mmol) was added, and the solution was
cooled to 0 ◦C. To this cooled solution was added a solution of the
diacylglycerol phosphoramidite (22 mg, 0.023 mmol) in CH2Cl2
(0.5 ml). The mixture was stirred for 2 h, slowly warming to room
temperature. The mixture was then cooled to −40 ◦C (aceto-
nitrile/dry ice) and m-chloroperbenzoic acid (50–80%, 11 mg,
0.04 mmol) was added. The mixture was stirred at −40 ◦C for
30 min, 0 ◦C for 1 h and then room temperature for 1 h. The
mixture was then diluted with CH2Cl2, washed with aqueous
NaHCO3, dried over Na2SO4, filtered, and concentrated in vacuo
and purified twice on silica gel (20% acetone/hexanes) to give
15 mg of a homogeneous protected PI derivative (68%). The
purified pentakisbenzyl ester (15 mg, 0.010 mmol) was dissolved
in THF:H2O (1.0 ml), palladium-on-carbon (10%, 14.7 mg) was
added, and the mixture was stirred under a hydrogen atmosphere
for 19 h at room temperature. The mixture was filtered, concen-
trated, redissolved in water, and lyophilized to give a C26-PI in the
phosphoric acid form as a white solid (8 mg, 84%).
Biophysical characterization of the C26-PI
Lipid films for differential scanning calorimetry were prepared
from DEPE (1,2-dielaidoyl-sn-glycero-3-phosphoethanolamine)
dissolved in chloroform/methanol (2:1, v/v), with or without
the addition of increasing molar fractions of other lipids. The
solvent was removed by evaporation with nitrogen. Final traces
of organic solvent were removed in a vacuum chamber attached to
a liquid nitrogen trap for 2–3 h. The lipid films were hydrated at
room temperature by vortex-mixing with 20 mM Pipes buffer,
pH 7.4, containing 0.14 M NaCl, 1 mM EDTA and 0.002%
sodium azide. The final lipid concentration was 5 mg/ml. Buffer
and lipid suspensions were degassed under vacuum before being
loaded into the sample or the reference cell, respectively, of a
NanoCal high-sensitivity calorimeter (CSC; American Forks, UT,
U.S.A.). A heating scan rate of 0.75 K/min was employed. The
observed phase transition was fitted with parameters describing
an equilibrium with a single van’t Hoff enthalpy and the transition
temperature reported as that for the fitted curve. The shift of the
bilayer to hexagonal phase transition temperature, occurring at
65 ◦C for the pure DEPE, provides a measure of the effect of
an additive on the curvature properties of the lipid. Data were
analysed with the program Origin 5.0.
c© 2004 Biochemical Society
944 R. Schneiter and others
Figure 1 Electron microscopic analysis of cells that are blocked in ceramide- and GPI-anchor-biosynthesis
Wild-type (YPH259; A), lcb1-100 (B) and gpi2-5A (C) conditional mutant cells were cultivated in minimal media and shifted to 37 ◦C for 4 h before fixation and processing for electron microscopy.
White arrows in (C) point to abnormal membrane extensions. n, nucleus; the scale bar represents 1 µm.
Table 1 Characterization of yeast nuclear fraction
Nuclear membranes were isolated from YPH259 wild-type cells. Relative enrichment of marker proteins in the homogenate was set at 1. Antibodies against the following proteins were used: Kar2p,
Nop1p, porin, Kex2p, carboxypeptidase Y and plasma membrane ATPase. Values represent averages of six independent preparations.
Subcellular compartment
Nuclear membrane/ER Mitochondria Golgi Vacuole Plasma membrane
Marker protein Kar2p Nop1p Porin Kex2p Carboxypeptidase Y ATPase
Fold enrichment 11 14 2 0.4 2 2
RESULTS AND DISCUSSION
A block in ceramide and GPI-anchor biosynthesis does not affect
the morphology of the nuclear envelope
Our previous observation of an altered nuclear envelope pheno-
type in the conditional acc1ts mutant suggested that fatty acid
elongation and hence the synthesis of C26 fatty-acid-containing
lipids might be important for maintaining a functional nuclear
envelope [18]. As ceramide is the major known C26-containing
lipid in yeast, we first examined whether a block in ceramide
synthesis would result in an altered morphology of the nuclear
envelope. Therefore a mutant with a conditional defect in the
rate-limiting enzyme of long-chain base synthesis, serine palmito-
yltransferase, lcb1-100 [24], was incubated in permissive or non-
permissive conditions for 4 h and the cells were examined by
transmission electron microscopy. This analysis revealed that
lcb1-100 mutant cells had a normal nuclear morphology ir-
respective of whether they were incubated at permissive or non-
permissive conditions, indicating that a block in long-chain-base
synthesis does not result in the structural alterations characteristic
of acc1ts mutant cells (Figure 1). These observations suggest that
ongoing ceramide synthesis is not required for maintaining a
functional nuclear envelope, which is consistent with the fact that
cells lacking the capacity to synthesize ceramide, due to muta-
tions in LAG1 and LAC1, display no aberrant nuclear morphology
[33].
To examine whether a block in GPI-anchor biosynthesis would
affect the morphology of the nuclear envelope, a conditional gpi2-
5A mutant, which blocks an early step in GPI-anchor biosynthesis
(the synthesis of N-acetylglucosaminyl PI [25]), was incubated in
permissive or non-permissive conditions for 4 h and the cells were
examined by transmission electron microscopy. In approx. 30%
of the gpi–5A mutant cells that were shifted to non-permissive
conditions, abnormal membrane profiles were observed (Fig-
ure 1). Extensions of what appear to be ER membranes were
frequently seen to emanate from the nuclear membrane shown by
arrows in Figure 1C). However, the clear separation of inner and
outer nuclear membrane, that is characteristic of acc1ts, was not
observed in the gpi2-5A mutant, indicating that a block in GPI
synthesis does not account for the nuclear envelope phenotype
observed in acc1ts. Similar extensions of the ER membrane
were observed previously in another conditional mutant in GPI
synthesis, mcd4-174 [34]. Thus elongated fatty acids, but not
sphingolipids or GPI-anchors with elongated fatty acids, appear
to be required for a normal nuclear morphology in yeast.
A mild-base-sensitive C26-containing lipid is present in the
nuclear and the plasma membranes
In a next step towards examining a possible role of a C26-con-
taining lipid in nuclear membrane integrity, we asked whether
yeast nuclear membranes contain any C26-substituted lipids apart
from ceramide. Therefore nuclei from wild-type cells were iso-
lated by sucrose density-gradient centrifugation [26]. This nuclear
fraction was enriched approx. 14-fold for the nuclear/nucleolar
protein Nop1p, and 11-fold for the soluble ER-resident protein
Kar2p (Table 1). The major contaminating organelles in these pre-
parations were mitochondria, vacuoles and the plasma membrane,
as judged by the 2-fold enrichments for porin, a major protein of
the outer mitochondrial membrane, for carboxypeptidase Y, a
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Table 2 Mild-base-sensitive and mild-base-resistant pools of C26 fatty
acids in nuclear and plasma membrane fractions
Release of C26 fatty acids from isolated nuclear and plasma membrane fractions after mild
(0.1 M NaOH, 30 ◦C, 1 h) or strong (2 M KOH, 80 ◦C, 16 h) alkaline hydrolysis. The relative
amount of C26 is given as mol % of the total fatty acids. Values represent means +− S.D. for three
independent determinations.
Membrane Mild alkaline treatment Strong alkaline treatment
Plasma membrane 1.3 +− 0.3 5.6 +− 0.9
Nuclear membrane 1.6 +− 0.4 1.5 +− 0.3
vacuolar hydrolase, and for the plasma-membrane proton-pump-
ing ATPase (Pma1p). The isolated nuclei appeared to be intact,
as visualized by epifluorescence microscopy of 4,6-diamidino-2-
phenylindole-stained samples (results not shown).
Lipid extracts prepared from the nuclear fraction were then
analysed for the presence of a mild-base-sensitive and mild-base-
resistant pool of the C26 fatty acid. Mild alkaline treatment re-
leases hydroxy esterified fatty acids, and is thus an indication
that the respective acyl chain is hydroxyl-bound. Hydrolysis of
amide-linked acyl groups as typically found in ceramides, on the
other hand, requires more stringent hydrolysis conditions (see
the Experimental section). Using mild and strong alkaline hydro-
lysis of lipid extracts from nuclear membranes, we could thus
distinguish between ceramide-bound C26 and a mild-base-sen-
sitive, possibly glycerophospholipid-bound, pool of C26. This
analysis revealed the presence of a small pool of mild-base-sen-
sitive C26 in the nuclear membrane of yeast, comprising approx.
1.6% of the total mild-base-sensitive fatty acid pool (Table 2).
The proportion of C26 did not significantly increase upon strong
alkaline hydrolysis, indicating that the pools of ceramide-bound
C26 in the nuclear membrane are not significantly greater than in
the mild-base-sensitive fraction. This is consistent with a low
abundance of ceramide and sphingolipids in the ER/nuclear mem-
brane.
To determine whether this mild-base-sensitive pool of C26 is
unique to the nuclear fraction, we compared the fatty acid pro-
files of isolated plasma membrane lipids to that of the nuclear
membrane after mild or strong alkaline hydrolysis. Plasma mem-
branes were isolated and were typically enriched more than
100-fold for the plasma-membrane proton-pumping ATPase
(Pma1p), as judged by Western blot analysis (results not shown)
[27]. GLC analysis of fatty acids released after mild base treatment
of plasma membrane lipids revealed the presence of a small mild-
base-sensitive pool of C26, comprising 1.3% of the released fatty
Table 3 Fatty acid distribution in individual phospholipid classes in yeast nuclear membrane
Relative proportion of the major phospholipid classes PC (phosphatidylcholine), PE (phosphatidylethanolamine), and PI in the nuclear membrane fraction and the positional distribution of fatty acids
in sn − 1 and sn − 2 positions of these phospholipid classes (in mol %). The relative abundance of fatty acids is given as percentage of total. Values represent means +− S.D. of three independent
determinations. nd, not detected.
PC (42 %) PE (32 %) PI (22 %)
Position Position Position
Fatty acid Total (%) sn − 1 sn − 2 Total (%) sn − 1 sn − 2 Total (%) sn − 1 sn − 2
C16:0 23.2 +− 2.3 88 35.8 +− 4.7 90 38.3 +− 4.3 76
C16:1 45.6 +− 6.4 50 50 27.5 +− 3.9 56 17.1 +− 2.8 86
C18:0 5.4 +− 0.9 79 4.6 +− 0.8 54 14.8 +− 2.5 69
C18:1 25.5 +− 2.9 94 31.4 +− 4.1 83 28.0 +− 3.4 89
C26 nd nd 1.4 +− 0.3 92
acids. While essentially no mild-base-resistant pool of C26 was
detected in the nuclear fraction, the plasma membrane contained
a significant fraction of mild-base-resistant C26. These results are
consistent with the predominant plasma membrane localization
of ceramide-containing sphingolipids and the presence of mild-
base-sensitive C26-containing lipid in both the nuclear and the
plasma membranes [35].
The mild-base-sensitive C26 is linked to the sn− 1 position of PI
The observation that mild base treatment resulted in release of
C26 suggested that the fatty acid could be bound to a glycerolipid.
To identify the nature of this lipid, individual glycerolipid classes
present in the lipid extract of nuclear membranes were separated
by two-dimensional TLC and analysed for the presence of the
mild-base-releasable C26 fatty acid. In this analysis, the mild-
base-sensitive C26 fatty acid could exclusively be detected in
the inositol-containing glycerophospholipid fraction. C26 was not
detectable in the more abundant glycerophospholipids, phospha-
tidylcholine or phosphatidylethanolamine.
To determine the positional distribution of the C26 fatty acid in
PI, phospholipids from the nuclear fraction were subjected to sn-2
specific cleavage by phospholipase A2. The released fatty acids
were separated from the lyso-lipids by TLC, and the chain-length
distribution of the released fatty acid and the one that remained
bound to the lyso-lipid was determined by GLC. This analysis
revealed that the C26 fatty acid was not released by phospholipase
A2 digestion and remained in the lyso-lipid fraction, indicating
that C26 is bound to the sn − 1 position of PI (Table 3). Control
experiments with phospholipase A2 digestion of a synthetic sn − 2
C26-substituted PC were performed to ascertain that the lipase can
cleave C26 if present in the sn − 2 position and hence that the
observed sn − 1 specificity is not due to a chain-length preference
of the enzyme (results not shown).
To determine whether the mild-base-sensitive pool of C26
identified in the plasma membrane is bound to the same lipid
as the one in the nuclear membrane, the analysis was repeated
with lipids isolated from the plasma membrane. As observed for
the nuclear membrane, the mild-base-sensitive pool of C26 in the
plasma membrane is also esterified to PI (Table 4).
The product of the ER-bound elongation reaction is likely to
be C26-CoA; the synthesis of the C26-PI is thus predicted to re-
quire an acyltransferase that is highly specific for the transfer of
C26 to the sn − 1 position of PI. Interestingly, VLCFAs of higher
plants are only found in phosphatidylserine [36], whereas in mam-
mals, they are predominately found esterified in the sn − 1 posi-
tion of phosphatidylcholine [37]. Yeast contains two glycerol-3-
phosphate/dihydroxyacetone phosphate acyltransferases, SCT1
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Table 4 Fatty acid distribution in individual phospholipid classes in the
yeast plasma membrane
Relative proportion of the major phospholipid classes PC (phosphatidylcholine), PE
(phosphatidylethanolamine), PI and PS (phosphatidylserine) in isolated yeast plasma membrane
fractions. Relative abundance of fatty acids are given as mol % of the total. Values represent
means +− S.D. for three independent determinations. nd, not detected.
Fatty acid PC (17 %) PE (20 %) PI (18 %) PS (33 %)
C16:0 53.8 +− 4.3 67.6 +− 6.1 58.3 +− 4.9 62.0 +− 2.9
C16:1 18.6 +− 1.1 8.1 +− 1.3 4.5 +− 0.7 5.5 +− 0.7
C18:0 9.0 +− 0.8 4.7 +− 0.8 26.1 +− 1.3 3.6 +− 0.4
C18:1 18.1 +− 2.2 19.2 +− 2.1 9.7 +− 1.3 28.2 +− 2.1
C26:0 nd nd 1.1 +− 0.3 nd
and GPT2, which together account for the major sn − 1-specific
acyltransferase activity [38]. Deletion of either one or the other
leaves the synthesis of the C26-PI intact (A. Conzelmann, personal
communication).
MS analysis of C26-substituted lipid molecular species
At this stage of the analysis of the mild-base-sensitive pool of
C26, it was still possible that the C26-substituted lipid was not a
genuine PI, but another lipid that co-migrates with PI in our two-
dimensional TLC experiment. We thus decided to analyse the
distribution of C26 by nano-ESI-MS/MS, which allows the rapid
and very sensitive qualitative and quantitative analysis of complex
membrane lipid mixtures [39]. Precursor ion scan analysis for the
presence of an ion fragment of a mass-to-charge (m/z) ratio of
395, corresponding to the C26 fatty acid, revealed five peaks with
m/z ratios of 975, 947, 921, 893 and 865. These correspond to PI
lipids with a sum of carbon atoms and double bonds of 44:1, 42:1,
40:0, 38:0 and 36:0 (Figure 2). Product ion analysis of these three
PI species revealed that PI of m/z 975 is composed of C26:0 and
C18:1. The PI of m/z 947 is composed of two molecular species,
one with C26:0 and C16:1, and the other with C24:0 and C18:1.
This second species is less abundant and accounts for approx.
20–30% of the PI 42:1. The PI of m/z 921 is again composed
of two molecular species: the major one containing C26:0 and
C14:0 (approx. 50–90%), and a minor one containing C24:0
and C16:0. The fourth peak at m/z 893 (PI 38:0) is composed
Figure 2 ESI MS/MS analysis of C26-containing molecular species of PI in the yeast nuclear membrane
Precursor ion scan analysis for the C26 fatty acid (m/z 395) of total lipids extracted from the nuclear fraction. Peak assignment to molecular species of PI is indicated.
of approximately equal quantities of a species with C26:0 and
C12:0 and another species with C24:0 and C14:0. The fifth peak
at m/z 865 (PI 36:0), finally, is composed of three species, with
a fatty acid composition of C18:0/C18:0, C26:0/C10:0 (≈20%),
and C24:0/C12:0 (≈10%).
This MS analysis is thus consistent with the notion that yeast
membranes contain PI as the sole C26-containing glycerophospho-
lipid. MS analysis of lipids from the plasma membrane revealed
the presence of the same five VLCFA-containing PI species that
were also observed in the nuclear fraction (results not shown).
In good agreement with the abundance of this lipid estimated by
GLC analysis, the C26-PIs comprise approx. 1% of all the inositol-
containing lipids, as determined by MS.
The specificity of the C26 substitution for the sn − 1 position is
interesting, and must be discussed in the context of the unusual
sn − 2 C26-PIs that are synthesized in the SLC1-1 yeast mutant.
This strain bypasses a ceramide requirement by synthesizing
novel sn − 2 C26-PIs that structurally and functionally mimic
sphingolipids, at least under standard growth conditions [18,19].
The fact that the sn − 2 C26-PI in the SLC1-1 mutant is glyco-
sylated to mannosyl-PIs and inositol-phosphate-mannosyl-PIs,
whereas the sn − 1 C26-PI that we identified in this study appears
not to be glycosylated, as indicated by the lack of detectable
amounts of mannosylated C26-PI species (at m/z 947 + 162 for
mannose; results not shown), suggests that sorting/glycosylation
and/or lipid remodelling is sensitive to the position of the C26 fatty
acid.
The existence of a remodelling system that operates on inositol-
containing lipids in yeast is indicated by the observation that GPI
anchors containing LCFA-PI are remodelled in the ER to either
ceramide or an sn − 2 C26-PI [20]. These VLCFA-containing
anchors are then remodelled further, resulting in the introduction
and exchange of defined ceramides [20].
Synthesis of C26-PI
Having identified a novel C26-containing lipid in the nuclear mem-
brane of yeast that might be important for maintaining a functional
and morphological intact nuclear envelope, we wondered whether
this lipid has any distinct biophysical properties that could not be
provided by the abundant LCFA-substituted glycerophospholipid.
Thus, to characterize the biophysical properties of the sn − 1
c© 2004 Biochemical Society
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Scheme 2 Synthesis of C26-PI
Steps (a–c) represent: (a) 5 equiv. tetrazole, CH2Cl2, 0 ◦C; (b) m-chloroperbenzoic acid, − 40 ◦C to 20 ◦C; (c) H2, 10 % Pd/C, THF-H2O, 20 ◦C.
Figure 3 Dependence of TM and TH on the mole fraction of C26-PI added to
DEPE liposomes
C26-PI, synthetic C26-PI was prepared by a convergent synthesis
(Scheme 2). First, the required sn-1-O-hexacosanoyl-sn-2-O-
palmitoylglyceryl phosphoramidite was prepared from chiral sol-
ketal in six steps (not shown): (i) protection of the sn − 3 hydroxy
group as the PMB ether; (ii) hydrolysis of the acetal; (iii, iv) se-
quential introduction of the sn − 1 hexacosanoyl and sn − 2 palmi-
toyl groups; (v) oxidative deprotection of the 3-hydroxy group;
and finally (vi) coupling with benzyloxychlorodi-isopropylphos-
phine. Coupling of the resulting diacylglycerylphosphoramidite to
1-hydroxy-2,3,4,5,6-pentakisbenzyloxy-D-myo-inositol followed
by oxidation gave the protected C26-PI in a 68% yield after
purification on silica gel. Catalytic hydrogenolysis removed the
benzyl ethers and benzyl esters to give the homogeneous product,
C26-PI, as a white solid in an 84% yield.
Biophysical characterization of C26-PI
The effects of the C26-PI on membrane curvature were then as-
sessed by examining the TH (bilayer to hexagonal transition tem-
perature) of liposomes composed of DEPE. When added to DEPE
liposomes at low mole fraction (0.1%), the C26-PI was among
the most potent agents to lower TH (Figure 3). Over the linear
Figure 4 Dependence of TM and TH of DEPE on the mole fraction of soya
bean PI added to DEPE liposomes
The upper-placed numbers in each panel indicate the slopes, and the lower-placed numbers
show the regression coefficients (R2) of the linear plots.
portion of the first three points, the addition of C26-PI lowers
TH by 3.03 +− 0.03 ◦C per mole fraction additive. Compared with
diacylglycerols or alkanes, the effect of the C26-PI on TH is ap-
proximately three or more times greater [40]. On the other hand,
the effect of C26-PI on the TM (Lα to Lβ phase transition temper-
ature) is approx. 10-fold smaller (Figure 3). A lowering of TM is
commonly found upon addition of amphiphiles to bilayers, and
has been interpreted as the effects of a ‘contaminant’ on the pure
DEPE [41]. However, substances that reduce the hydration of the
membrane interface are found to raise TM even though they lower
TH [42]. Thus the effect of C26-PI is a consequence of its effect
on hydrocarbon packing, rather than on the membrane interfacial
properties. This is also likely to be the case since PI is an anionic
lipid, and should inhibit hexagonal phase formation by preventing
bilayer–bilayer contact. We can compare the action of C26-PI with
other amphiphiles. In general, amphiphiles, even as long as 24 car-
bon atoms, raise TH [41]. This includes phosphatidylcholine,
studied up to acyl-chain lengths of 22 carbon atoms [41]. Thus
C26-PI is unusual, perhaps because of the mismatch between
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Figure 5 Model of highly curved membrane domains and their possible
stabilization by VLCFA-containing lipids: structure of the highly asymmetric
C26-PI
A schematic drawing of a 180◦ membrane bend with lipids containing LCFAs is shown in (A). A
possible formation of a ‘void volume’ within the hydrophobic core of the membrane is indicated
by arrows. VLCFA lipids (filled-in head groups) in either the outer (B) or the luminal (C) layer
of the membrane could occupy this volume, and thereby stabilize the curved domain. (D) shows
the structure of the highly asymmetric C26-PI that was identified in the present study.
the two acyl chains. In comparison, a natural mixture of PI
from soya bean, not having a high content of VLCFAs (33.2%
C16:0, 46.8% C18:2), raises TH, as does lyso-PI from bovine
liver (Figure 4, and results not shown). The effect of lyso-PI is
smaller, possibly because it does not completely partition into the
membrane (results not shown).
The biophysical properties of the C26-PI are thus consistent with
a possible role of this lipid in stabilizing highly curved membrane
structures, i.e. structures that are likely to be present in the
nuclear envelope (Figure 5). The potent lowering of TH by C26-PI
indicates that it can stabilize structures with negative curvature of
a lipid monolayer, which might affect the morphology of a bilayer
membrane if the C26-PI clusters at particular domains (Figure 5C).
The NPC spans the nuclear envelope within a specialized pore
membrane domain that is generally thought to be formed by
a fusion of the inner and outer nuclear membrane, resulting in a
tight 180◦ turn of the membrane. Based on electron microscopy,
the membrane at this domain has been estimated to have a diameter
of approx. 30 nm [43,44], which is considerably smaller than the
≈60 nm diameter typically observed in COP (coatamer protein)
II coated vesicles [45].
Even though this C26-PI is present only in small amounts
(approx. 1 mol% of all PIs), the local concentration of the lipid
in a membrane domain may be higher and sufficient to exert the
proposed stabilizing function on curved domains. The likelihood
of C26-PI sequestering to specific domains in the membrane is
made stronger by the finding that the shift of TM with increasing
mole fraction of C26-PI is non-linear (Figure 3). This would be
consistent with the lipid not distributing uniformly in the bilayer.
This non-linearity is not seen with the mixed PI from soya bean
(Figure 4).
The fact that this lipid is not restricted to the nuclear membrane
does not preclude a possible role of this lipid in stabilizing curved
membrane domains, as such domains are also found in the form
of finger-like invaginations at the plasma membrane of yeast [46].
Direct experimental evidence for a possible structural function of
this lipid in vivo, however, must await the availability of mutants
that more specifically affect the synthesis of this lipid.
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